Fargo ND 超重临床试验
8项针对 超重的研究正在 Fargo及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
招募中3 期
- Valley Weight Loss Clinic, Fargo
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Lillestol Research LLC /ID# 281978, Fargo
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Lillestol Research LLC, Fargo
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Lillestol Research, Fargo
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Fargo
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- Lillestol Research, Fargo
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- Lillestol Research LLC, Fargo
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Fargo
其他城市的 超重试验
- San Antonio, TX33 项研究
- Houston, TX33 项研究
- Chicago, IL28 项研究
- Orlando, FL25 项研究
- Miami, FL23 项研究
- Las Vegas, NV23 项研究
- Dallas, TX20 项研究
- Atlanta, GA20 项研究
- New York City, NY19 项研究
- Jacksonville, FL19 项研究
- Washington, DC19 项研究
- Austin, TX18 项研究
Fargo的其他研究
- 非小细胞肺癌14 项研究
- 肺癌13 项研究
- 癌症（所有类型）11 项研究
- 黑色素瘤9 项研究
- 肥胖症9 项研究
- 前列腺癌8 项研究
- 乳腺癌7 项研究
- 结直肠癌7 项研究
- 胰腺癌6 项研究
- 2型糖尿病6 项研究
- 结肠癌6 项研究
- 直肠癌6 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。